Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | THRB | P10828 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 2/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9906564 | 0.95 | MAPT (0.38) | L3MBTL1TDP1THRBKMT2AMEN1 | |
| SCHEMBL25009119 | 0.94 | KMT2A (0.39) | L3MBTL1TDP1THRBKMT2AMEN1 | |
| SCHEMBL12434513 | 0.93 | THRB (0.41) | L3MBTL1TDP1THRBKMT2AMEN1 | |
| SCHEMBL15583458 | 0.92 | PPARG (0.38) | THRBKMT2AMAPTLMNAPPARD | |
| SCHEMBL5961817 | 0.92 | KMT2A (0.39) | L3MBTL1TDP1THRBKMT2AMAPT | |
| SCHEMBL18588611 | 0.92 | L3MBTL1 (0.44) | L3MBTL1TDP1THRBKMT2AMEN1 | |
| SCHEMBL10000351 | 0.91 | KMT2A (0.44) | L3MBTL1TDP1THRBKMT2AMEN1 | |
| SCHEMBL15397356 | 0.91 | THRB (0.40) | L3MBTL1TDP1THRBKMT2AMEN1 | |
| SCHEMBL19844241 | 0.91 | PPARG (0.42) | L3MBTL1TDP1THRBKMT2AMAPT | |
| SCHEMBL19844243 | 0.91 | THRB (0.42) | L3MBTL1TDP1THRBKMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9541690-B2 | Film using polymerizable liquid crystal composition containing peeling preventive agent | JNC CORPORATION (JP) | 2017-01-10 | — | — | US | disclosed |
| US-20140308462-A1 | FILM USING POLYMERIZABLE LIQUID CRYSTAL COMPOSITION CONTAINING PEELING PREVENTIVE AGENT | JNC PETROCHEMICAL CORPORATION (JP) | 2014-10-16 | — | — | US | disclosed |
| US-20120274888-A1 | OPTICALLY ANISOTROPIC SUBSTANCE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-11-01 | — | — | US | disclosed |
| US-8048496-B2 | Polymerizable liquid crystal compound, liquid crystal composition and polymer | JNC CORPORATION (JP) | 2011-11-01 | — | — | US | disclosed |
| US-20100297367-A1 | OPTICALLY ANISOTROPIC SUBSTANCE | CHISSO CORPORATION (JP) | 2010-11-25 | — | — | US | disclosed |
| US-20100096591-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND POLYMER | CHISSO CORPORATION | 2010-04-22 | — | — | US | disclosed |
| US-7597945-B2 | Optical compensation film; mixture of three (meth)acrylate monomers: e.g. 2,7-bis(acryloyloxyhexyloxy-1,4-phenylenecarbonyloxy)fluorene, a bis 2-fluoroacrylate monomer, and a cyanobiphenyloxyalkanol ester of (meth)acrylic acid; hardness, heat resistance, weatherability, colorless, LC physical properties | CHISSO CORPORATION (JP) | 2009-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100096591-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND POLYMER | PKN1, ZYX, OXER1 | L3MBTL1 1227/4885TDP1 2567/4885THRB 3732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.